Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

TELA Bio Inc has a consensus price target of $6.75 based on the ratings of 7 analysts. The high is $15 issued by Canaccord Genuity on March 28, 2023. The low is $1.25 issued by Piper Sandler on November 14, 2025. The 3 most-recent analyst ratings were released by Lake Street, Canaccord Genuity, and Piper Sandler on December 1, 2025, November 18, 2025, and November 14, 2025, respectively. With an average price target of $2.75 between Lake Street, Canaccord Genuity, and Piper Sandler, there's an implied 186.37% upside for TELA Bio Inc from these most-recent analyst ratings.
1calculated from analyst ratings
| Buy Now | Get Alert | ||||||
|---|---|---|---|---|---|---|---|
| 12/01/2025 | Buy Now | 212.4% | Lake Street | $6 → $3 | Maintains | Buy | Get Alert |
| 11/18/2025 | Buy Now | 316.54% | Canaccord Genuity | $7 → $4 | Maintains | Buy | Get Alert |
| 11/14/2025 | Buy Now | 30.17% | Piper Sandler | $2 → $1.25 | Reiterates | Neutral → Neutral | Get Alert |
| 11/14/2025 | Buy Now | 420.67% | Citizens | $7 → $5 | Maintains | Market Outperform | Get Alert |
| 03/21/2025 | Buy Now | 628.94% | Canaccord Genuity | $12 → $7 | Maintains | Buy | Get Alert |
| 03/21/2025 | Buy Now | 628.94% | Citizens Capital Markets | $12 → $7 | Maintains | Market Outperform | Get Alert |
| 03/21/2025 | Buy Now | 108.27% | Piper Sandler | $5 → $2 | Downgrade | Overweight → Neutral | Get Alert |
| 11/08/2024 | Buy Now | 420.67% | Piper Sandler | $8 → $5 | Maintains | Overweight | Get Alert |
| 10/04/2024 | Buy Now | 1149.61% | Canaccord Genuity | $12 → $12 | Maintains | Buy | Get Alert |
| 08/13/2024 | Buy Now | 1149.61% | JMP Securities | $15 → $12 | Maintains | Market Outperform | Get Alert |
| 08/13/2024 | Buy Now | 733.07% | Lake Street | $14 → $8 | Maintains | Buy | Get Alert |
| 08/13/2024 | Buy Now | 733.07% | Piper Sandler | $10 → $8 | Maintains | Overweight | Get Alert |
| 08/13/2024 | Buy Now | 1149.61% | Canaccord Genuity | $14 → $12 | Maintains | Buy | Get Alert |
| 07/25/2024 | Buy Now | 1357.88% | Canaccord Genuity | $14 → $14 | Maintains | Buy | Get Alert |
| 05/10/2024 | Buy Now | 941.34% | Piper Sandler | $12 → $10 | Reiterates | Overweight → Overweight | Get Alert |
| 03/22/2024 | Buy Now | 1462.01% | JMP Securities | → $15 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/22/2024 | Buy Now | 1149.61% | Piper Sandler | $15 → $12 | Maintains | Overweight | Get Alert |
| 12/27/2023 | Buy Now | 1357.88% | Lake Street | $14 → $14 | Reiterates | Buy → Buy | Get Alert |
| 11/10/2023 | Buy Now | 1462.01% | JMP Securities | $20 → $15 | Maintains | Market Outperform | Get Alert |
| 03/28/2023 | Buy Now | 1462.01% | Canaccord Genuity | → $15 | Reiterates | → Buy | Get Alert |
| 03/22/2023 | Buy Now | 1982.68% | JMP Securities | → $20 | Reiterates | → Market Outperform | Get Alert |
The latest price target for TELA Bio (NASDAQ:TELA) was reported by Lake Street on December 1, 2025. The analyst firm set a price target for $3.00 expecting TELA to rise to within 12 months (a possible 212.40% upside). 7 analyst firms have reported ratings in the last year.
The latest analyst rating for TELA Bio (NASDAQ:TELA) was provided by Lake Street, and TELA Bio maintained their buy rating.
There is no last upgrade for TELA Bio
The last downgrade for TELA Bio Inc happened on March 21, 2025 when Piper Sandler changed their price target from $5 to $2 for TELA Bio Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of TELA Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for TELA Bio was filed on December 1, 2025 so you should expect the next rating to be made available sometime around December 1, 2026.
While ratings are subjective and will change, the latest TELA Bio (TELA) rating was a maintained with a price target of $6.00 to $3.00. The current price TELA Bio (TELA) is trading at is $0.96, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.